XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.26.1

Note 7 - Stockholders' Equity | 3 Months Ended
--- | ---
Mar. 31, 2026
Notes to Financial Statements |
Equity [Text Block] | Note 7 – Stockholders’ Equity Preferred Series F Convertible Stock Purchase History On June 26, 2022, the Company entered into the Series F Agreement with Alpha Capital Anstalt ("Alpha"). Pursuant to the terms of the Series F Agreement, the Board of Directors of the Company (the “Board”) designated a new series of Preferred Stock, the Series F, and authorized the sale and issuance of up to 35,000 shares of Series F with a stated value of $1,000 per share. Pursuant to the Series F Agreement, sales of Series F are accompanied by warrants equal to the number of issuable shares upon conversion of the Series F to Common Stock (the “Series F Warrants”). Additional Investment Right The Series F Agreement provides Alpha the right to purchase up to an additional $25,000,000 stated value of Series F, after their initial 10,000 Series F purchased on June 26, 2022, and accompanying warrants (the “Additional Investment Right” or “AIR”). Under the AIR, the Series F and Series F Warrants are initially convertible and exercisable at a conversion and exercise price equal to the volume-weighted average price of the Company’s Common Stock for three trading days prior to the date Alpha gives notice to the Company that it will exercise its AIR. Under the terms of the AIR, conversion and exercise prices are subject to downward adjustment for any equity instrument or equity-linked instrument sold or granted at an effective price per share that is lower than the initial conversion and exercise price (“Down Round Provision”). See Note 8 for warrant related disclosures. On February 7, 2025, Alpha and the Company executed a funding agreement in which Alpha agreed to exercise its AIR quarterly to provide financing to the Company for the next twelve months, with such amounts and timing of funding to be agreed to by the parties. As consideration for Alpha’s commitment to provide additional funding, the Company agreed to (i) extend the period in which Alpha can exercise its AIR by extending the termination date of December 31, 2025 to June 1, 2026 and (ii) granting Alpha certain registration rights related to the Series F Alpha currently holds and will receive upon further exercises of its AIR. The Company filed the required registration statement to register 6,500,000 shares of Common Stock which was declared effective by the SEC on April 25, 2025. During the three months ended March 31, 2026, we issued the following Series F pursuant to the exercise of the AIR by Alpha:
| ● | On January 2, 2026, we issued 500 Series F to Alpha upon the exercise of their AIR and received $500,000 of gross proceeds. The Series F are initially convertible into 586,441 shares of Common Stock at an initial conversion price of $0.8526 and Series F Warrants to purchase up to 586,441 shares of Common Stock at an initial exercise price of $0.8526. The Series F Warrants are immediately exercisable upon issuance and have a three-year term. This issuance triggered down round provisions embedded in certain outstanding equity-linked instruments (the "January 2026 Down Round Trigger"). The impacts of this trigger event have been disclosed below.
During the three months ended March 31, 2025, we issued the following Series F pursuant to the exercise of the AIR by Alpha: ● On February 7, 2025, we issued 1,000 Series F to Alpha upon the exercise of their AIR and received $1,000,000 of gross proceeds. The Series F are initially convertible into 450,390 shares of Common Stock at an initial conversion price of $2.2203 and Series F Warrants to purchase up to 450,390 shares of Common Stock at an initial exercise price of $2.2203. The Series F Warrants are immediately exercisable upon issuance for a period of three years. As of March 31, 2026, this issuance of Series F had been fully converted to shares of Common Stock. ● On March 17, 2025, we issued 500 Series F to Alpha upon the exercise of their AIR and received $500,000 of gross proceeds. The Series F are initially convertible into 415,420 shares of Common Stock at an initial conversion price of $1.2036 and Series F Warrants to purchase up to 415,420 shares of Common Stock at an initial exercise price of $1.2036. The Series F Warrants are immediately exercisable upon issuance and have a three-year term. This issuance resulted in down round provisions embedded within previously issued Series F and Series F Warrants being triggered (the “March 2025 Down Round Trigger”), including the Series F and Series F Warrants issued on February 7, 2025. See Down Round Triggers and Deemed Dividends resulting from such triggers in Note 7 below. As of March 31, 2026, this issuance of Series F had been fully converted to shares of Common Stock. Since the execution of the Series F Agreement, the Company has sold and issued Series F and Series F Warrants to Alpha or investors that Alpha has assigned the AIR for cash proceeds through the exercise of the AIR. As of March 31, 2026, a total of 500 Series F shares remain available for issuance. A summary of the Series F activity for the three months ended March 31, 2026, is as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | Original |  |  | Shares |  |  |  |  |  |  |  |  |  |  | Shares |  |  | Conversion |  |  | Shares |
|  | Shares |  |  | Gross |  |  | Net |  |  | Conversion |  |  | Outstanding |  |  | Series F |  |  | Series F |  |  | Outstanding |  |  | Price at |  |  | Issuable at |
Date of Purchase |  | Purchased |  |  | Proceeds |  |  | Proceeds |  |  | Price |  |  | December 31, 2025 |  |  | Issued |  |  | Converted |  |  | March 31, 2026 |  |  | March 31, 2026 |  |  | March 31, 2026 |
November 15, 2023 |  |  | 1,850 |  |  | $ | 1,850,000 |  |  | $ | 1,850,000 |  |  | $ | 124.7000 |  |  |  | 150 |  |  |  | — |  |  |  | — |  |  |  | 150 |  |  | $ | 0.8294 |  |  |  | 180,854 |
March 6, 2024 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 950,000 |  |  |  | 60.2900 |  |  |  | 100 |  |  |  | — |  |  |  | — |  |  |  | 100 |  |  |  | 0.8294 |  |  |  | 120,569 |
May 31, 2024 |  |  | 1,050 |  |  |  | 1,050,000 |  |  |  | 1,025,000 |  |  |  | 32.1500 |  |  |  | 135 |  |  |  | — |  |  |  | — |  |  |  | 135 |  |  |  | 0.8294 |  |  |  | 162,768 |
July 18, 2025 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 1,000,000 |  |  |  | 1.4000 |  |  |  | 422 |  |  |  | — |  |  |  | (422 | ) |  |  | — |  |  |  | 0.8526 | (i) |  |  | — |
July 21, 2025 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 1.4000 |  |  |  | 500 |  |  |  | — |  |  |  | (500 | ) |  |  | — |  |  |  | 0.8526 | (i) |  |  | — |
July 24, 2025 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 1,000,000 |  |  |  | 2.1900 |  |  |  | 1,000 |  |  |  | — |  |  |  | (1,000 | ) |  |  | — |  |  |  | 0.8526 | (i) |  |  | — |
October 6, 2025 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 1,000,000 |  |  |  | 2.3427 |  |  |  | 815 |  |  |  | — |  |  |  | (640 | ) |  |  | 175 |  |  |  | 0.8526 | (i) |  |  | 205,255 |
November 24, 2025 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 1.1347 |  |  |  | 500 |  |  |  | — |  |  |  | (197 | ) |  |  | 303 |  |  |  | 0.8526 | (i) |  |  | 355,384 |
December 22, 2025 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 0.9615 |  |  |  | 500 |  |  |  | — |  |  |  | — |  |  |  | 500 |  |  |  | 0.8526 | (i) |  |  | 586,441 |
January 2, 2026 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 0.8526 |  |  |  | — |  |  |  | 500 |  |  |  | — |  |  |  | 500 |  |  |  | 0.8526 |  |  |  | 586,441 |
Total March 31, 2026 |  |  | 8,900 |  |  | $ | 8,900,000 |  |  | $ | 8,825,000 |  |  | $ | — |  |  |  | 4,122 |  |  |  | 500 |  |  |  | (2,759 | ) |  |  | 1,863 |  |  | $ | — |  |  |  | 2,197,712 |
(i) - Reflects the conversion price after the January 2026 Down Round Trigger that was triggered with the sale of Series F on January 2, 2026. |
A summary of the Series F activity for the three months ended March 31, 2025, is as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | Original |  |  | Shares |  |  |  |  |  |  |  |  |  |  | Shares |  |  | Conversion |  |  | Shares |
|  | Shares |  |  | Gross |  |  | Net |  |  | Conversion |  |  | Outstanding |  |  | Series F |  |  | Series F |  |  | Outstanding |  |  | Price at |  |  | Issuable at |
Date of Purchase |  | Purchased |  |  | Proceeds |  |  | Proceeds |  |  | Price |  |  | December 31, 2024 |  |  | Issued |  |  | Converted |  |  | March 31, 2025 |  |  | March 31, 2025 |  |  | March 31, 2025 |
November 15, 2023 |  |  | 1,850 |  |  | $ | 1,850,000 |  |  | $ | 1,850,000 |  |  | $ | 124.7000 |  |  |  | 150 |  |  |  | — |  |  |  | — |  |  |  | 150 |  |  | $ | 1.1000 |  |  |  | 136,364 |
March 6, 2024 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 950,000 |  |  |  | 60.2900 |  |  |  | 435 |  |  |  | — |  |  |  | (335 | ) |  |  | 100 |  |  |  | 1.1000 |  |  |  | 90,909 |
April 12, 2024 |  |  | 1,050 |  |  |  | 1,050,000 |  |  |  | 1,050,000 |  |  |  | 37.0000 |  |  |  | 1,050 |  |  |  | — |  |  |  | (1,050 | ) |  |  | — |  |  |  | 1.1000 |  |  |  | — |
May 31, 2024 |  |  | 1,050 |  |  |  | 1,050,000 |  |  |  | 1,025,000 |  |  |  | 32.1500 |  |  |  | 1,050 |  |  |  | — |  |  |  | (525 | ) |  |  | 525 |  |  |  | 1.1000 |  |  |  | 477,273 |
July 25, 2024 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 23.1500 |  |  |  | 500 |  |  |  | — |  |  |  | (500 | ) |  |  | — |  |  |  | 1.1000 |  |  |  | — |
August 27, 2024 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 20.1900 |  |  |  | 500 |  |  |  | — |  |  |  | — |  |  |  | 500 |  |  |  | 1.1000 |  |  |  | 454,545 |
October 1, 2024 (i) |  |  | 1,500 |  |  |  | — |  |  |  | — |  |  |  | 12.0000 |  |  |  | 1,500 |  |  |  | — |  |  |  | — |  |  |  | 1,500 |  |  |  | 1.1000 |  |  |  | 1,363,636 |
December 18, 2024 |  |  | 750 |  |  |  | 750,000 |  |  |  | 750,000 |  |  |  | 5.2500 |  |  |  | 750 |  |  |  | — |  |  |  | — |  |  |  | 750 |  |  |  | 1.2036 | (ii) |  |  | 623,131 |
February 7, 2025 |  |  | 1,000 |  |  |  | 1,000,000 |  |  |  | 1,000,000 |  |  |  | 2.2200 |  |  |  | — |  |  |  | 1,000 |  |  |  | — |  |  |  | 1,000 |  |  |  | 1.2036 | (ii) |  |  | 830,841 |
March 17, 2025 |  |  | 500 |  |  |  | 500,000 |  |  |  | 500,000 |  |  |  | 1.2000 |  |  |  | — |  |  |  | 500 |  |  |  | — |  |  |  | 500 |  |  |  | 1.2036 |  |  |  | 415,420 |
Total March 31, 2025 |  |  | 9,700 |  |  | $ | 8,200,000 |  |  | $ | 8,125,000 |  |  | $ | — |  |  |  | 5,935 |  |  |  | 1,500 |  |  |  | (2,410 | ) |  |  | 5,025 |  |  | $ | — |  |  |  | 4,392,119 |
(ii) - Reflects the conversion price after the March 2025 Down Round Trigger that was triggered with the sale of Series F on March 17, 2025. |
During the three months ended March 31, 2026 and 2025, the dividends accrued on the Series F were $30,997 and $67,651, respectively. As of March 31, 2026 and December 31, 2025, accrued dividends on the Series F total $125,850 and $948,532 which are included in accrued expenses on the unaudited consolidated balance sheets, at the rate per share (as a percentage of the $1,000 stated par value per share of Series F) of 5% per annum, beginning on the purchase date. On January 9, 2026, the Company made a cash dividend payment of $853,679. Series G Convertible Preferred Stock On November 5, 2025, the Company executed a certificate of designation (the "Series G Certificate of Designation") of preferences, rights and limitations of the Series G Convertible Preferred Stock, designating 100,000 shares of Series G Convertible Preferred Stock ("Series G"), with a par value of $0.001 and a stated value of $1,000. The shares of Series G have no voting rights except as provided in the Series G Certificate of Designation or as otherwise required by law and only receive dividends when declared by the Board of Directors. Series G have liquidation preferences over common stockholders and are pari passu to Series F. On November 5, 2025, the Company entered into a Securities Purchase Agreement with certain existing investors, one of which is Alpha (the "Purchasers"), pursuant to which, subject to the terms and conditions set forth therein, the Company agreed to issue and sell to the Purchasers in a registered direct offering an aggregate of up to 100,000 shares of the Series G. Subject to the terms and conditions of the Series G Certificate of Designation, the Series G were convertible immediately upon issuance, at an initial conversion price equal to $1.2300 per share. The conversion price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based adjustments in the event of any issuances of Common Stock or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable conversion price (subject to certain exceptions) ("Down Round Provision"). The Company agreed to sell, and the Purchasers, severally and not jointly, agreed to purchase an aggregate of 12,000 shares of Series G on the initial closing date. On November 10, 2025, the Company sold 12,000 shares of Series G and received net cash proceeds of $11,507,338. After issuance of the Series G, the Company sold Series F and Series F Warrants on November 24, and December 22, 2025 with conversion and exercise prices of $1.1347 and $$0.9615, respectively. This triggered the Down Round Provision embedded within the Series G and reduced the initial conversion price of $1.2300 to $1.1347 and further to $0.9615 on December 2025. During the three months ended March 31, 2026, the conversion price was further reduced from $0.9615 to $0.8526 for the 6,190 Series G outstanding upon the January 2026 Down Round Trigger. The impacts of this trigger event are described below. On March 4 and 5, 2026, the Company sold 250 and 2,000 shares of Series G, respectively, and received aggregate net proceeds of $2,250,000. The Series G are convertible immediately upon issuance, at an initial conversion price equal to $1.00 per share. As of March 31, 2026, the Company has issued a total of 14,250 Series G shares and 85,750 Series G shares remain available for issuance. A summary of the Series G activity for the three months ended March 31, 2026, is as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | Original |  |  | Shares |  |  |  |  |  |  |  |  |  |  | Shares |  |  | Conversion |  |  | Shares |
|  | Shares |  |  | Gross |  |  | Net |  |  | Conversion |  |  | Outstanding |  |  | Series G |  |  | Series G |  |  | Outstanding |  |  | Price at |  |  | Issuable at |
Date of Purchase |  | Purchased |  |  | Proceeds |  |  | Proceeds |  |  | Price |  |  | December 31, 2025 |  |  | Issued |  |  | Converted |  |  | March 31, 2026 |  |  | March 31, 2026 |  |  | March 31, 2026 |
November 10, 2025 |  |  | 12,000 |  |  | $ | 12,000,000 |  |  | $ | — |  |  | $ | 1.2300 |  |  |  | 6,190 |  |  |  | — |  |  |  | (6,190 | ) |  |  | — |  |  | $ | 0.9615 |  |  |  | — |
March 4, 2026 |  |  | 250 |  |  |  | 250,000 |  |  |  | — |  |  |  | 1.0000 |  |  |  | — |  |  |  | 250 |  |  |  | (250 | ) |  |  | — |  |  |  | 1.0000 |  |  |  | — |
March 5, 2026 |  |  | 2,000 |  |  |  | 2,000,000 |  |  |  | — |  |  |  | 1.0000 |  |  |  | — |  |  |  | 2,000 |  |  |  | (1,500 | ) |  |  | 500 |  |  |  | 1.0000 |  |  |  | 500,000 |
Total March 31, 2026 |  |  | 14,250 |  |  | $ | 14,250,000 |  |  | $ | — |  |  | $ | — |  |  |  | 6,190 |  |  |  | 2,250 |  |  |  | (7,940 | ) |  |  | 500 |  |  | $ | — |  |  |  | 500,000 |
Common Stock Issuances Conversions During the three months ended March 31, 2026 and 2025, a total of 0 and 700,000 shares of Common Stock were issued for the conversion of $0 and $770,000 of principal outstanding on a convertible note at a conversion ratio of $0 and $1.10, respectively (see Note 5). During the three months ended March 31, 2026 and 2025, a total of 2,759 and 2,410 Series F were converted into a total of 3,235,983 and 2,190,908 shares of Common Stock, respectively, at a conversion price of $0.8526 and $1.10, respectively. During the three months ended March 31, 2026 and 2025, a total of 7,940 and 0 Series G were converted into a total of 9,010,144 and 0 shares of Common Stock, respectively. During the three months ended March 31, 2026, the Series G conversion prices upon conversion were $0.8526 and $1.000. Warrant Exercises During the three months ended March 31, 2026, we issued 1,128,050 shares of Common Stock for the exercise of Series F Warrants with an exercise price of $0.8526 and received aggregate cash proceeds of $961,775. Further, during the three months ended March 31, 2026 we issued 358,806 shares of Common Stock for the cashless exercise of 671,797 Series F Warrants with an exercise price of $0.8526. During the three months ended March 31, 2025, we issued 267,849 shares of Common Stock for the exercise of Series B Warrants with an exercise price of $1.9445 and an aggregate exercise price of $520,833. The Company agreed to credit $350,000 of the aggregate exercise price pursuant to a settlement reached with the Series B Warrant holder over a dispute and received approximately $171,000 of cash proceeds. Down Round Triggers and Deemed Dividends We have several outstanding equity classified and equity-linked instruments that include down round provisions in which the conversion or exercise price is adjusted down upon the Company’s issuance of its Common Stock or common stock equivalents at a price per share that is less than the conversion or exercise price of the equity-linked instruments. As of March 31, 2026, these equity-linked instruments include the Series F, Series F Warrants, Series G and Series B Warrants. Upon a down round provision being triggered in an equity classified instrument, we compute the incremental value provided to the holder for the reduction in conversion or exercise price using a Black-Scholes model to determine the fair value of the equity-linked instruments prior to and after the down round provision trigger. The incremental value is recorded within stockholders’ equity as a deemed dividend. Specifically, deemed dividends increase additional paid in capital and increase accumulated deficit and increase total net loss or decrease to total net income attributable to common stockholders in computing earnings per share on the condensed consolidated statements of operations and comprehensive income. During the periods ended March 31, 2026 and 2025, we used the following assumptions in the Black-Scholes model used to compute the incremental value for the conversion price reductions in the Series F and Series G and Series F Warrants and Series B Warrants:
|  | For the Three Months Ended
|  | March 31,
|  | 2026 |  | 2025
Expected term (years) |  | 0.50 - 2.75 |  | 2.00 - 3.00
Volatility |  | 144.52 - 158.40% |  | 140.71 - 161.65%
Risk-free rate |  | 3.51 - 3.58% |  | 4.03 - 4.06%
Dividend yield |  | 0.00% |  | 0.00%
Below is a summary of the deemed dividends resulting from the January 2026 Down Round Trigger that reduced the conversion and exercise price of outstanding Series F and Series G, and Series F Warrants, as applicable, during the three months ended March 31, 2026.
Deemed Dividend on Series F and G Preferred Stock |
|  | Description of |  | Series F and G Shares |  |  | Conversion Price |  |  | Conversion Price |  |  | Incremental Value |
Date of Trigger Event |  | Trigger Event |  | Triggered |  |  | Prior to Trigger |  |  | After Trigger |  |  | Deemed Dividend |
January 2, 2026 |  | January 2026 Down Round Trigger |  |  | 10,324,493 |  |  | $ | 0.9615 |  |  | $ | 0.8526 |  |  | $ | 1,291,691 |
|  | Deemed Dividends on Series F and G Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 1,291,691 |
Deemed Dividend on Series F Warrants |
January 2, 2026 |  | January 2026 Down Round Trigger |  |  | 4,752,651 |  |  | $ | 0.9615 |  |  | $ | 0.8526 |  |  |  | 57,792 |
|  | Deemed Dividends on Series F Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 57,792 |
|  | Total Deemed Dividends Series F and G Preferred Stock and Series F Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 1,349,483 |
Below is a summary of the deemed dividends resulting from the March 2025 Down Round Trigger that reduced the conversion and exercise price of outstanding Series F Preferred Stock and Series F Warrants during the three months ended March 31, 2025.
Deemed Dividends on Series F Preferred Stock |
| Description of |  | Series F |  |  | Conversion Prices |  |  | Conversion Price |  |  | Incremental Value |
Date of Trigger Event | Trigger Event |  | Triggered |  |  | Prior to Trigger |  |  | After Trigger |  |  | Deemed Dividend |
March 17, 2025 | March 2025 Down Round Trigger |  |  | 5,025 |  |  | $ | 2.22 - 5.25 |  |  | $ | 1.2000 |  |  | $ | 976,637 |
| Deemed Dividends on Series F Preferred Stock |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 976,637 |
Deemed Dividends on Series F Warrants |
March 17, 2025 | March 2025 Down Round Trigger |  |  | 593,247 |  |  | $ | 2.22 - 5.25 |  |  | $ | 1.2000 |  |  |  | 79,695 |
| Deemed Dividends on Series F Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 79,695 |
| Total Deemed Dividends Series F PS and Series F Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 1,056,332 |
Series F and Series F Warrants issued prior to December 2024 have conversion and exercise prices equal to $1.10 and were not impacted by the March 2025 Down Round Trigger. |
Stock-based Compensation The Company determines the fair value of awards granted under the 2017 Omnibus Equity Incentive Plan (the “Equity Plan”) based on the fair value of its Common Stock on the date of grant. Stock-based compensation expenses related to grants under the Equity Plan are included in general and administrative expenses on the condensed consolidated statements of operations and comprehensive income. Restricted Stock Units (“RSUs”) For the three months ended March 31, 2026, a summary of RSU activity is as follows:
|  |  |  |  |  | Weighted Average |
|  |  |  |  |  | Grant Date |
|  | Shares |  |  | Fair Value |
Outstanding as of December 31, 2025 |  |  | 52,040 |  |  | $ | 34.26 |
Granted |  |  | 858,997 |  |  |  | 0.95 |
Cancelled |  |  | — |  |  |  | — |
Vested and released |  |  | (25,000 | ) |  |  | 1.06 |
Outstanding as of March 31, 2026 |  |  | 886,037 |  |  |  | 2.90 |
Vested as of March 31, 2026 |  |  | 12,437 |  |  |  | 137.44 |
Unvested as of March 31, 2026 |  |  | 873,600 |  |  | $ | 0.98 |
For the three months ended March 31, 2026, the aggregate fair value of RSU awards at the time of grant was $812,642 based on the market price of our Common Stock on the date of grant. For the three months ended March 31, 2026, the Company recognized $74,609 of stock-based compensation expense and had approximately $744,000 of unrecognized stock-based compensation expense related to RSUs, which will be amortized over approximately thirty six months. For the three months ended March 31, 2025, a summary of RSU activity is as follows:
|  |  |  |  |  | Weighted Average |
|  |  |  |  |  | Grant Date |
|  | Shares |  |  | Fair Value |
Outstanding as of December 31, 2024 |  |  | 7,293 |  |  | $ | 324.64 |
Granted |  |  | 72,194 |  |  |  | 2.10 |
Cancelled |  |  | (1,072 | ) |  |  | 264.60 |
Vested and released |  |  | — |  |  |  | — |
Outstanding as of March 31, 2025 |  |  | 78,415 |  |  |  | 28.57 |
Vested as of March 31, 2025 |  |  | 8,015 |  |  |  | 255.33 |
Unvested as of March 31, 2025 |  |  | 70,400 |  |  | $ | 2.75 |
For the three months ended March 31, 2025, the aggregate fair value of RSU awards at the time of vesting was $151,640. For the three months ended March 31, 2025, the Company recognized $49,880 of stock-based compensation expense and had approximately $137,886 of unrecognized stock-based compensation expense related to RSUs, which will be amortized over approximately fifteen months.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 20 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 20 -Name Accounting Standards Codification -Section S25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480100/505-10-S45-2 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 20 -Name Accounting Standards Codification -Section S50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-2 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 20 -Name Accounting Standards Codification -Section S25 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 4 -Subparagraph (SAB Topic 4.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481520/505-30-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 20 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 1.D.2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479921/505-20-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 20 -Name Accounting Standards Codification -Section S50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479951/505-20-S50-3 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 1.B.3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480148/855-10-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 20 -Name Accounting Standards Codification -Section S25 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479982/505-20-S25-3 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480657/210-10-S50-11 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration